Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Products

Further concessionary prices agreed for October

  • News

The Department of Health and National Assembly for Wales have agreed further concessionary prices for the following items for October 2017 prescriptions.

Drug
Strength
Form
Price
Diamorphine
30mg
powder for solution for injection ampoules
£16.52
Levetiracetam
1g
tablets (60)
£69.85
Levetiracetam
500mg
tablets (60)
£41.10
Pramipexole
88mcg
tablets (30)
£11.24
Tolterodine
2mg
tablets (56)
£4.10

Initial concessionary prices for October were announced on October 11, and updated on October 20.

Table

View full table

Are there any medicines you think should be on this list?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Products
Latest News & Analysis

NHSE backs £1.5m scheme to ‘expand’ London MPharm placements

Marathon effort kicks off Pharmacist Support fundraising drive

‘Pool of blood’: Half-naked man stages frenzied attack outside pharmacy

Opinion: Antisemitism ruling is illogical and disturbing

See All
UsernamePublicRestriction

Register

CD009022

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By